Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920

Marko Skelin; Dario Rahelić; Petar Skelin; Marko Lucijanic

doi:10.2337/dc19-2039

Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920

Marko Skelin, Dario Rahelić, Petar Skelin, Marko Lucijanic

Research output: Contribution to journal › Comment/debate › Research › peer-review

Original language	English
Journal	Diabetes Care. Supplement
Volume	43
Issue number	2
Pages (from-to)	e28-e29
ISSN	0149-5992
DOIs	https://doi.org/10.2337/dc19-2039
Publication status	Published - 1 Feb 2020

Access to Document

10.2337/dc19-2039

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Skelin, M., Rahelić, D., Skelin, P., & Lucijanic, M. (2020). Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920. Diabetes Care. Supplement, 43(2), e28-e29. https://doi.org/10.2337/dc19-2039

Skelin, Marko ; Rahelić, Dario ; Skelin, Petar et al. / Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920. In: Diabetes Care. Supplement. 2020 ; Vol. 43, No. 2. pp. e28-e29.

@article{008b3d4aabc042a6903ea71ce815c237,

title = "Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920",

author = "Marko Skelin and Dario Raheli{\'c} and Petar Skelin and Marko Lucijanic",

year = "2020",

month = feb,

day = "1",

doi = "10.2337/dc19-2039",

language = "English",

volume = "43",

pages = "e28--e29",

journal = "Diabetes Care. Supplement",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "2",

}

Skelin, M, Rahelić, D, Skelin, P & Lucijanic, M 2020, 'Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920', Diabetes Care. Supplement, vol. 43, no. 2, pp. e28-e29. https://doi.org/10.2337/dc19-2039

Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920. / Skelin, Marko; Rahelić, Dario; Skelin, Petar et al.
In: Diabetes Care. Supplement, Vol. 43, No. 2, 01.02.2020, p. e28-e29.

Research output: Contribution to journal › Comment/debate › Research › peer-review

TY - JOUR

T1 - Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920

AU - Skelin, Marko

AU - Rahelić, Dario

AU - Skelin, Petar

AU - Lucijanic, Marko

PY - 2020/2/1

Y1 - 2020/2/1

UR - http://www.scopus.com/inward/record.url?scp=85078635062&partnerID=8YFLogxK

U2 - 10.2337/dc19-2039

DO - 10.2337/dc19-2039

M3 - Comment/debate

SN - 0149-5992

VL - 43

SP - e28-e29

JO - Diabetes Care. Supplement

JF - Diabetes Care. Supplement

IS - 2

ER -

Skelin M, Rahelić D, Skelin P, Lucijanic M. Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920. Diabetes Care. Supplement. 2020 Feb 1;43(2):e28-e29. doi: 10.2337/dc19-2039

Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920

Access to Document

AUB Link

Other files and links

Cite this